Cigna Group
CIAPI behind this page
CI Q2 2025 request
Playground key active
/api/financials?ticker=CI&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Home delivery and specialty revenues · Evernorth Health Services | 19,974 | 18,017 | +10.9% |
| Network revenues · Evernorth Health Services | 30,582 | 25,276 | +21.0% |
| Other revenues · Evernorth Health Services | 3,433 | 2,897 | +18.5% |
| Product | 53,649 | 45,101 | +19.0% |
| Product · All Other Segments | 14 | 16 | -12.5% |
| Product · Corporate and Eliminations | -354 | -1,105 | +68.0% |
| Product · Evernorth Health Services | 53,989 | 46,190 | +16.9% |
| Service | 4,137 | 3,647 | +13.4% |
| Service Other | 114 | 152 | -25.0% |
| Service, Fees And Other Revenues [Member] | 4,137 | 3,647 | +13.4% |
| Service, Fees And Other Revenues [Member] · All Other Segments | 19 | 19 | 0.0% |
| Service, Fees And Other Revenues [Member] · Cigna Healthcare | 1,679 | 1,716 | -2.2% |
| Service, Fees And Other Revenues [Member] · Corporate and Eliminations | -1,366 | -1,381 | +1.1% |
| Service, Fees And Other Revenues [Member] · Evernorth Health Services | 3,805 | 3,293 | +15.5% |
| Premiums Earned Net | 9,156 | 11,454 | -20.1% |
Show Product Lines breakouts |
|||
| Employer insured · Cigna Healthcare | 4,684 | 4,350 | +7.7% |
| Individual and Family Plans · Cigna Healthcare | 941 | 975 | -3.5% |
| Other · Cigna Healthcare | 462 | 1,220 | -62.1% |
| Stop loss · Cigna Healthcare | 1,879 | 1,665 | +12.9% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 78 | 115 | -32.2% |
| Cigna Healthcare · International Health | 1,026 | 891 | +15.2% |
| Cigna Healthcare · Operating Segments | 8,992 | 11,308 | -20.5% |
| Cigna Healthcare · U.S. Healthcare | 7,966 | 10,417 | -23.5% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 86 | 31 | +177.4% |
| Net Investment Income | 236 | 321 | -26.5% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 73 | 77 | -5.2% |
| Cigna Healthcare · Operating Segments | 127 | 172 | -26.2% |
| Evernorth Health Services · Operating Segments | 31 | 65 | -52.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 5 | 7 | -28.6% |
| Revenue | 67,178 | 60,523 | +11.0% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 184 | 227 | -18.9% |
| Cigna Healthcare · Operating Segments | 10,798 | 13,196 | -18.2% |
| Evernorth Health Services · Operating Segments | 57,825 | 49,548 | +16.7% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | -1,629 | -2,448 | +33.5% |
| Cost of Revenue | 53,268 | 44,492 | +19.7% |
Show Business Segments breakouts |
|||
| Evernorth Health Services · Operating Segments | 54,939 | 46,852 | +17.3% |
| Policyholder Benefits And Claims Incurred Net | 7,749 | 9,515 | -18.6% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 7,482 | 9,312 | -19.7% |
| Selling, General & Administrative | 3,433 | 3,684 | -6.8% |
| Amortization Of Intangible Assets | 422 | 420 | +0.5% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 6 | 4 | +50.0% |
| Evernorth Health Services · Operating Segments | 416 | 416 | 0.0% |
| Benefits Losses And Expenses | 64,872 | 58,111 | +11.6% |
| Operating Income | 2,306 | 2,412 | -4.4% |
| Other Non-Operating Income (Expense) | -337 | -375 | +10.1% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 2 | 2 | 0.0% |
| Evernorth Health Services · Operating Segments | 1 | -2 | +150.0% |
| Net Investment Gain Loss | 52 | -48 | +208.3% |
| Income Before Taxes | 2,021 | 1,989 | +1.6% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | -20 | -17 | -17.6% |
| Cigna Healthcare · Operating Segments | 1,098 | 1,205 | -8.9% |
| Evernorth Health Services · Operating Segments | 1,430 | 1,299 | +10.1% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -487 | -498 | +2.2% |
| Income Tax Expense (Benefit) | 389 | 360 | +8.1% |
| Net Income | 1,632 | 1,629 | +0.2% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 100 | 81 | +23.5% |
| Parent | 1,532 | 1,548 | -1.0% |
| Retained Earnings | 1,532 | 1,548 | -1.0% |
| Net Income Loss Attributable To Noncontrolling Interest | 100 | 81 | +23.5% |
| Net Income Loss Available To Common Stockholders Basic | 1,532 | 1,548 | -1.0% |
| EPS (Basic) | 5.76 | 5.51 | +4.5% |
| EPS (Diluted) | 5.71 | 5.45 | +4.8% |
| Comprehensive Income | 1,306 | 1,430 | -8.7% |
| Wtd Avg Shares (Diluted) | 268,154 | 284,052 | -5.6% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 4,329 | 6,788 | -36.2% |
| Short-Term Investments | 813 | — | — |
Show Investment Type breakouts |
|||
| Debt Securities | 443 | — | — |
| Equity Securities | 15 | — | — |
| Mortgages | 105 | — | — |
| Short Term Investments | 250 | — | — |
| Receivables Net Current | 31,148 | — | — |
| Inventory | 5,967 | 5,173 | +15.3% |
| Other Assets Current | 2,466 | 2,664 | -7.4% |
| Total Current Assets | 44,723 | 46,215 | -3.2% |
| Reinsurance Recoverables Non Current | 4,297 | 4,595 | -6.5% |
| Non-Current Assets | |||
| Long Term Investments | 15,662 | — | — |
Show Investment Type breakouts |
|||
| Debt Securities | 7,946 | — | — |
| Equity Securities | 561 | — | — |
| Mortgages | 1,206 | — | — |
| Other Long Term Investments | 4,832 | — | — |
| Policy Loans | 1,117 | — | — |
| Goodwill | 44,375 | 44,258 | +0.3% |
| Other Non-Current Assets | 2,929 | 3,276 | -10.6% |
| Total Assets | 151,651 | 155,446 | -2.4% |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 3,621 | 3,551 | +2.0% |
| Intangible Assets Net Excluding Goodwill | 28,671 | 30,176 | -5.0% |
| Separate Account Assets | 7,373 | — | — |
| Current Liabilities | |||
| Insurance And Contractholder Liabilities Current | 6,015 | — | — |
| Accounts Payable | 9,938 | 9,275 | +7.1% |
| Debt Current | 4,288 | — | — |
| Total Current Liabilities | 56,779 | 55,373 | +2.5% |
| Commercial Paper (Q) | — | — | — |
Show Credit Facility breakouts |
|||
| Commercial Paper | 1.2 | — | — |
| Non-Current Liabilities | |||
| Insurance And Contractholder Liabilities Noncurrent | 10,157 | — | — |
| Deferred Tax Liabilities | 6,781 | 6,953 | -2.5% |
| Other Non-Current Liabilities | 3,651 | 3,538 | +3.2% |
| Total Liabilities | 111,221 | 113,919 | -2.4% |
| Other Liabilities | |||
| Pharmacy And Service Costs Payable | 29,460 | 27,503 | +7.1% |
| Accrued Expenses And Other Liabilities | 7,078 | 9,003 | -21.4% |
| Long Term Debt And Capital Lease Obligations | 26,480 | — | — |
| Separate Accounts Liability | 7,373 | 7,431 | -0.8% |
| Stockholders' Equity | |||
| Common Stock | 4 | 4 | 0.0% |
| Additional Paid In Capital Common Stock | 31,588 | 31,048 | +1.7% |
| Accumulated Other Comprehensive Income | -2,816 | -2,442 | -15.3% |
| Retained Earnings | 45,564 | 42,132 | +8.1% |
| Treasury Stock Value | -34,126 | -29,410 | -16.0% |
| Total Stockholders' Equity | 40,214 | 41,332 | -2.7% |
| Minority Interest | 216 | 195 | +10.8% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 40,430 | 41,527 | -2.6% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -934 | -919 | -1.6% |
| Accumulated Other Comprehensive Income | -2,816 | -2,442 | -15.3% |
| Accumulated Translation Adjustment | -120 | -180 | +33.3% |
| Additional Paid In Capital | 31,588 | 31,048 | +1.7% |
| Common Stock | 4 | 4 | 0.0% |
| Net long-duration insurance and contractholder liabilities measurement adjustments | -2,815 | -1,743 | -61.5% |
| Noncontrolling Interest | 216 | 195 | +10.8% |
| Parent | 40,214 | 41,332 | -2.7% |
| Retained Earnings | 45,564 | 42,132 | +8.1% |
| Securities and derivatives | 1,053 | 400 | +163.2% |
| Treasury Stock Common | -34,126 | -29,410 | -16.0% |
| Total Liabilities & Equity | 151,651 | 155,446 | -2.4% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 1,356 | 1,479 | -8.3% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 11 | 3 | +266.7% |
| Cigna Healthcare · Operating Segments | 164 | 237 | -30.8% |
| Evernorth Health Services · Operating Segments | 1,171 | 1,220 | -4.0% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 10 | 19 | -47.4% |
| Increase Decrease In Deferred Income Taxes | -292 | -199 | -46.7% |
| Increase Decrease In Accounts And Other Receivables | -6,398 | -7,313 | +12.5% |
| Change in Inventory | 726 | 472 | +53.8% |
| Increase Decrease In Reinsurance Recoverable | -402 | -559 | +28.1% |
| Increase Decrease In Insurance Liabilities | 1,702 | -125 | +1461.6% |
| Increase Decrease In Pharmacy And Service Costs Payable | 995 | 7,820 | -87.3% |
| Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities | -1,020 | -15 | -6700.0% |
| Increase Decrease In Other Operating Capital Net | 417 | 225 | +85.3% |
| Net Cash from Operations | 34 | 5,105 | -99.3% |
| Investing Activities | |||
| Proceeds From Sale Of Debt And Equity Securities | 272 | 393 | -30.8% |
| Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities | 553 | 414 | +33.6% |
| Proceeds From Collection Of Loans Receivable | 90 | 37 | +143.2% |
| Proceeds From Sale And Maturity Of Other Investments | 431 | 451 | -4.4% |
| Payments To Acquire Debt And Equity Securities | -1,512 | -493 | -206.7% |
| Payments To Acquire Mortgage Notes Receivable | -62 | -52 | -19.2% |
| Payments To Acquire Other Investments | -761 | -865 | +12.0% |
| Payments For Proceeds From Property Plant And Equipment | -612 | -670 | +8.7% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | 2,346 | — | — |
| Payments To Acquire Equity Method Investments | -327 | -335 | +2.4% |
| Other Investing Activities | -18 | -15 | -20.0% |
| Net Cash from Investing | 400 | -1,135 | +135.2% |
| Financing Activities | |||
| Additions To Contract Holders Funds | 74 | 84 | -11.9% |
| Withdrawal From Contract Holders Funds | -137 | -135 | -1.5% |
| Proceeds From Repayments Of Other Short Term Debt | 296 | -467 | +163.4% |
| Repayments Of Long Term Debt | -1,600 | -3,000 | +46.7% |
Show Debt Instrument breakouts |
|||
| $900 million, 3.250% Notes due April 2025 · Senior Notes | -900 | — | — |
| Share Repurchases | -2,620 | -5,012 | +47.7% |
| Proceeds From Issuance Of Common Stock | 141 | 221 | -36.2% |
| Payments Of Dividends Common Stock | -813 | -793 | -2.5% |
| Proceeds From Payments For Other Financing Activities | -355 | -198 | -79.3% |
| Net Cash from Financing | -5,014 | -4,838 | -3.6% |
| Supplemental | |||
| Income Taxes Paid | 350 | 567 | -38.3% |
| Interest Paid | 680 | 643 | +5.8% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 35 | -12 | +391.7% |
| Net Change in Cash | -4,545 | -880 | -416.5% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 4,386 | 7,457 | -41.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4,386 | 6,832 | -35.8% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.